Literature DB >> 15366652

Allergic contact dermatitis prevalence in patients with eczematous external otitis.

Murat Yariktas1, Mehmet Yildirim, Fehmi Doner, Vahide Baysal, Harun Dogru.   

Abstract

Eczematous external otitis, because of its basic allergic nature, tends to be chronic or recurrent. The purpose of our study was to investigate the association between allergic contact dermatitis and chronic eczematous external otitis. Sixty-six patients with eczematous external otitis and 48 healthy volunteers were included in this study. All the patients were tested with an epicutaneous patch test. In the study group, the average recurrent attack rate was 6.1+/-1.5 (between 4-9 times during the last year) in the patch test positive eczematous external otitis patients, and 4.9+/-1.3 (between 4-8 times during the last year) in the patch test negative patients (p = 0.002). The epicutaneous patch test was positive in 19 (28.8%) out of 66 cases with chronic eczematous external otitis, and in 3 (6.3%) out of 48 cases in the control group. The difference between the two groups was statistically significant (p = 0.003). The most common reactions were due to neomycin sulfate and potassium dichromate in this study. These results suggest that, in some cases eczematous external otitis may be considered as a form of delayed type hypersensitivity to allergen stimuli. Patients suffering from eczematous external otitis symptoms should be investigated for allergens.

Entities:  

Mesh:

Year:  2004        PMID: 15366652

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  3 in total

1.  [Topical immunomodulation. A milestone for the treatment of therapy-resistant noninfectious chronic external otitis?].

Authors:  P P Caffier; W Harth; B Mayelzadeh; H Haupt; H Scherer; B Sedlmaier
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

2.  Skin prick test reactivity in patients with chronic eczematous external otitis.

Authors:  Ozlem Celebi Erdivanli; K Cagdas Kazikdas; Zerrin Ozergin Coskun; Munir Demirci
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-12-15       Impact factor: 3.372

3.  Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Victoria Montoro; Carlos Asensio; Ángel Martínez; Juan Lorente; Francisco J Rodríguez; José Montojo; Javier Gavilanes; Pedro Sarría; Cristóbal Langdon; Eduard Prades
Journal:  J Int Med Res       Date:  2018-08-24       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.